Dopamine agonist therapy (cabergoline) is the standard primary treatment for prolactinoma. Classical work does not replace it. In some patients with idiopathic or stress-related hyperprolactinaemia, classical treatment may produce measurable reduction in prolactin as the underlying pattern resolves — but in true prolactinoma, pharmacological treatment is essential.

Some patients with prolactinoma eventually successfully taper off cabergoline with sustained prolactin normalisation and tumour shrinkage — this is considered and managed by endocrinology. Classical treatment does not affect this decision. Tapering should always be specialist-directed based on prolactin levels and tumour imaging.

Yes — acupuncture is commonly used alongside prolactinoma management on cabergoline, and we coordinate with your treating team. Patients with large tumours or visual symptoms should have specialist imaging and review before treatment beyond straightforward supportive acupuncture. Classical treatment does not affect tumour size; cabergoline does.

Successful treatment of hyperprolactinaemia (whether prolactinoma, medication-induced, or other cause) typically restores menstrual and ovulatory function, and fertility is often achievable. Classical treatment supports constitutional recovery during this phase. Reproductive endocrinology input is appropriate when fertility is actively pursued. —

Yes — HICAPS-equipped at both Belmont (Perth) and Geraldton (Mid West WA) clinics for on-the-spot rebates with most major Australian health funds.